| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | antigen binding | 7.69e-06 | 190 | 50 | 6 | GO:0003823 | |
| GeneOntologyBiologicalProcess | immunoglobulin production | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 2.72e-19 | 241 | 61 | 17 | GO:0002377 |
| GeneOntologyBiologicalProcess | production of molecular mediator of immune response | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 1.54e-15 | 403 | 61 | 17 | GO:0002440 |
| GeneOntologyBiologicalProcess | adaptive immune response | IGKV1-39 IGKV1-37 IGKV1-27 RAG1 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 1.92e-11 | 838 | 61 | 18 | GO:0002250 |
| GeneOntologyCellularComponent | immunoglobulin complex | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 3.41e-22 | 166 | 61 | 17 | GO:0019814 |
| GeneOntologyCellularComponent | Sec61 translocon complex | 8.33e-05 | 5 | 61 | 2 | GO:0005784 | |
| GeneOntologyCellularComponent | translocon complex | 1.25e-04 | 6 | 61 | 2 | GO:0071256 | |
| GeneOntologyCellularComponent | blood microparticle | 8.31e-04 | 144 | 61 | 4 | GO:0072562 | |
| Domain | Plug_translocon | 5.42e-06 | 2 | 44 | 2 | PF10559 | |
| Domain | SecY_su_dom | 5.42e-06 | 2 | 44 | 2 | IPR023201 | |
| Domain | SecY | 5.42e-06 | 2 | 44 | 2 | PF00344 | |
| Domain | SECY_1 | 5.42e-06 | 2 | 44 | 2 | PS00755 | |
| Domain | SECY_2 | 5.42e-06 | 2 | 44 | 2 | PS00756 | |
| Domain | - | 5.42e-06 | 2 | 44 | 2 | 1.10.3370.10 | |
| Domain | Translocon_Sec61/SecY_plug_dom | 5.42e-06 | 2 | 44 | 2 | IPR019561 | |
| Domain | SecY_CS | 5.42e-06 | 2 | 44 | 2 | IPR030659 | |
| Domain | SecY/SEC61-alpha | 5.42e-06 | 2 | 44 | 2 | IPR002208 | |
| Domain | BRINP | 1.62e-05 | 3 | 44 | 2 | IPR033237 | |
| Domain | MAC_perforin | 2.41e-04 | 10 | 44 | 2 | IPR001862 | |
| Domain | MACPF | 2.94e-04 | 11 | 44 | 2 | PF01823 | |
| Domain | MACPF | 3.53e-04 | 12 | 44 | 2 | SM00457 | |
| Domain | MACPF | 3.53e-04 | 12 | 44 | 2 | IPR020864 | |
| Domain | Quinoprotein_ADH-like_supfam | 6.93e-03 | 53 | 44 | 2 | IPR011047 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 2.10e-11 | 61 | 47 | 8 | M27581 |
| Pathway | REACTOME_FCGR_ACTIVATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 5.86e-11 | 69 | 47 | 8 | M27108 |
| Pathway | REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 5.86e-11 | 69 | 47 | 8 | M27150 |
| Pathway | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 7.42e-11 | 71 | 47 | 8 | M1078 |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 7.42e-11 | 71 | 47 | 8 | M27203 |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.98e-10 | 80 | 47 | 8 | M6121 |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 2.42e-10 | 82 | 47 | 8 | M27110 |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.57e-10 | 86 | 47 | 8 | M27206 |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.57e-10 | 86 | 47 | 8 | M601 |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.92e-10 | 87 | 47 | 8 | M27205 |
| Pathway | REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 7.99e-10 | 95 | 47 | 8 | M29842 |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.03e-09 | 98 | 47 | 8 | M27152 |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 STAT2 | 1.68e-09 | 154 | 47 | 9 | M39007 |
| Pathway | REACTOME_COMPLEMENT_CASCADE | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.70e-09 | 115 | 47 | 8 | M19752 |
| Pathway | REACTOME_PARASITE_INFECTION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.96e-09 | 116 | 47 | 8 | M29843 |
| Pathway | REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.24e-08 | 134 | 47 | 8 | M29840 |
| Pathway | REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.40e-08 | 136 | 47 | 8 | M27207 |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 2.07e-08 | 143 | 47 | 8 | M27107 |
| Pathway | REACTOME_LEISHMANIA_INFECTION | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 ENTPD5 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 3.65e-08 | 219 | 47 | 9 | M29836 |
| Pathway | REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 6.64e-08 | 166 | 47 | 8 | M608 |
| Pathway | REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.60e-07 | 186 | 47 | 8 | M27175 |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 1.88e-07 | 190 | 47 | 8 | M8240 |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 | 2.21e-07 | 194 | 47 | 8 | M16312 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF20A PREB IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 AP1B1 TSC2 IGKV1D-39 FCHO2 IGKV1D-16 IGKV1D-12 | 4.38e-07 | 725 | 47 | 13 | M27507 |
| Pathway | REACTOME_ADAPTIVE_IMMUNE_SYSTEM | KIF20A IGKV1-39 SEC61A2 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 AP1B1 UBE3B IGKV1D-39 IGKV1D-16 IGKV1D-12 SEC61A1 | 1.96e-06 | 828 | 47 | 13 | M1058 |
| Pathway | REACTOME_SARS_COV_INFECTIONS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 STAT2 | 2.11e-05 | 471 | 47 | 9 | M39009 |
| Pathway | REACTOME_HEMOSTASIS | KIF20A IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-12 PCDH7 | 6.45e-05 | 679 | 47 | 10 | M8395 |
| Pathway | REACTOME_VIRAL_INFECTION_PATHWAYS | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 AP1B1 IGKV1D-39 IGKV1D-16 IGKV1D-12 STAT2 | 5.72e-04 | 888 | 47 | 10 | M48034 |
| Pathway | REACTOME_INFECTIOUS_DISEASE | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 AP1B1 ENTPD5 IGKV1D-39 IGKV1D-16 IGKV1D-12 STAT2 | 6.83e-04 | 1081 | 47 | 11 | M27548 |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 1.61e-03 | 18 | 47 | 2 | MM15336 | |
| Pathway | WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS | 1.79e-03 | 19 | 47 | 2 | M39473 | |
| Pathway | REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN | 2.19e-03 | 21 | 47 | 2 | M27634 | |
| Pathway | KEGG_PROTEIN_EXPORT | 2.87e-03 | 24 | 47 | 2 | M6981 | |
| Pubmed | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 3.74e-26 | 20 | 62 | 11 | 10427970 | |
| Pubmed | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 9.90e-26 | 9 | 62 | 9 | 6777049 | |
| Pubmed | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 1.12e-21 | 16 | 62 | 9 | 17124007 | |
| Pubmed | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 4.75e-21 | 18 | 62 | 9 | 20399194 | |
| Pubmed | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1D-39 IGKV1D-13 | 1.32e-17 | 11 | 62 | 7 | 6795447 | |
| Pubmed | Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis. | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1D-39 IGKV1D-13 | 1.32e-17 | 11 | 62 | 7 | 279004 |
| Pubmed | Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes. | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1D-39 IGKV1D-13 | 1.32e-17 | 11 | 62 | 7 | 6767723 |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-13 | 1.51e-16 | 77 | 62 | 10 | 15608191 |
| Pubmed | IGKV1-17 IGKV1-12 IGKV3D-15 IGKV1D-42 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 7.73e-16 | 17 | 62 | 7 | 8223863 | |
| Pubmed | IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.86e-15 | 36 | 62 | 8 | 11298326 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 6086934 | ||
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated O regions. | 5.38e-08 | 5 | 62 | 3 | 1907917 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 18480044 | ||
| Pubmed | Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma. | 3.13e-06 | 2 | 62 | 2 | 6776411 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8325334 | ||
| Pubmed | Phage display of a human antibody against Clostridium tetani toxin. | 3.13e-06 | 2 | 62 | 2 | 7926831 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 27826231 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 38467629 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 38071226 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8372513 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24415779 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 20025061 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 15193423 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 6091049 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21844384 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 37793345 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 6402305 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 6264318 | ||
| Pubmed | Negative regulation of TSC1-TSC2 by mammalian D-type cyclins. | 1.87e-05 | 4 | 62 | 2 | 16357142 | |
| Pubmed | Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology. | 1.87e-05 | 4 | 62 | 2 | 34686860 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 3927006 | ||
| Pubmed | The Sec61 complex is located in both the ER and the ER-Golgi intermediate compartment. | 1.87e-05 | 4 | 62 | 2 | 10212142 | |
| Pubmed | 3.12e-05 | 5 | 62 | 2 | 9565615 | ||
| Pubmed | 4.67e-05 | 6 | 62 | 2 | 16705175 | ||
| Pubmed | 9.60e-05 | 133 | 62 | 4 | 15144186 | ||
| Pubmed | 1.27e-04 | 143 | 62 | 4 | 22516433 | ||
| Pubmed | The human immunoglobulin kappa locus. Characterization of the duplicated A regions. | 1.39e-04 | 10 | 62 | 2 | 1551402 | |
| Pubmed | Cardiomyocyte DNA synthesis and binucleation during murine development. | 1.39e-04 | 10 | 62 | 2 | 8945939 | |
| Pubmed | 2.04e-04 | 12 | 62 | 2 | 9631292 | ||
| Pubmed | 2.41e-04 | 13 | 62 | 2 | 16571631 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.58e-04 | 497 | 62 | 6 | 36774506 | |
| Pubmed | Daple coordinates organ-wide and cell-intrinsic polarity to pattern inner-ear hair bundles. | 4.70e-04 | 18 | 62 | 2 | 29229865 | |
| Pubmed | 5.24e-04 | 19 | 62 | 2 | 20953190 | ||
| Pubmed | 7.72e-04 | 23 | 62 | 2 | 16267237 | ||
| Pubmed | Endogenously nitrated proteins in mouse brain: links to neurodegenerative disease. | 1.07e-03 | 27 | 62 | 2 | 16800626 | |
| Pubmed | 1.07e-03 | 27 | 62 | 2 | 25133637 | ||
| Pubmed | 1.23e-03 | 261 | 62 | 4 | 33277362 | ||
| Pubmed | 1.37e-03 | 122 | 62 | 3 | 30773093 | ||
| Pubmed | 1.63e-03 | 708 | 62 | 6 | 39231216 | ||
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 1.64e-03 | 130 | 62 | 3 | 26598620 | |
| Cytoband | 2p12 | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 8.79e-33 | 117 | 62 | 18 | 2p12 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p11 | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 7.36e-28 | 213 | 62 | 18 | chr2p11 |
| GeneFamily | Immunoglobulin kappa locus at 2p11.2 | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.07e-31 | 83 | 44 | 18 | 351 |
| Coexpression | RASHI_RESPONSE_TO_IONIZING_RADIATION_6 | IGKV1-39 IGKV1-27 SEC61A2 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-13 IGKV1D-12 | 3.78e-13 | 132 | 59 | 10 | MM996 |
| Coexpression | SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN | 5.94e-06 | 16 | 59 | 3 | M41742 | |
| Coexpression | HAY_BONE_MARROW_PLASMA_CELL | 1.21e-05 | 132 | 59 | 5 | M39205 | |
| Coexpression | SMID_BREAST_CANCER_ERBB2_UP | 2.39e-05 | 152 | 59 | 5 | M3102 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN | 5.13e-05 | 32 | 59 | 3 | M2118 | |
| Coexpression | GSE15659_TREG_VS_TCONV_UP | 7.45e-05 | 193 | 59 | 5 | M3534 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN | 8.82e-05 | 200 | 59 | 5 | M4560 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000_k-means-cluster#5 | IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 | 1.42e-08 | 183 | 52 | 8 | Arv_SC_fibroblast_1000_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000_k-means-cluster#3 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 | 1.42e-08 | 183 | 52 | 8 | Arv_SC-HD_1000_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500_k-means-cluster#2 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 | 1.38e-07 | 163 | 52 | 7 | Arv_SC-hpx_blastocyst_500_K2 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500_k-means-cluster#3 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 | 2.24e-07 | 175 | 52 | 7 | Arv_SC-H9hpx_500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000_k-means-cluster#4 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 | 2.09e-06 | 244 | 52 | 7 | Arv_SC-H9hpx_1000_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_2500_k-means-cluster#4 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 | 1.12e-05 | 315 | 52 | 7 | Arv_SC-HD_2500_K4 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_2500_k-means-cluster#1 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 | 1.54e-05 | 331 | 52 | 7 | Arv_SC-H9hpx_2500_K1 |
| CoexpressionAtlas | PP_HSC_top-relative-expression-ranked_2500_k-means-cluster#3 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 | 1.79e-05 | 339 | 52 | 7 | PP_HSC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_2500_k-means-cluster#5 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 | 1.86e-05 | 341 | 52 | 7 | Arv_SC_fibroblast_2500_K5 |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 SLC6A11 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 | 2.15e-05 | 986 | 52 | 11 | Arv_SC-HD_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 SLC6A11 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 | 2.15e-05 | 986 | 52 | 11 | Arv_SC_fibroblast_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-27 IGKV1-17 SLC6A11 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 MUC19 IGKV3D-15 IGKV1D-39 | 2.17e-05 | 987 | 52 | 11 | Arv_SC-H9hpx_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | IGKV1-39 IGKV1-27 IGKV1-17 SLC6A11 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 MUC19 IGKV3D-15 IGKV1D-39 | 2.17e-05 | 987 | 52 | 11 | Arv_SC-hpx_blastocyst_1000 |
| CoexpressionAtlas | AravindRamakr_StemCell-H9hpx_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 | 2.41e-05 | 492 | 52 | 8 | Arv_SC-H9hpx_500 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 | 2.41e-05 | 492 | 52 | 8 | Arv_SC-hpx_blastocyst_500 |
| CoexpressionAtlas | ratio_induced-Ectoderm_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | TOM1L2 IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 PCDH7 | 3.37e-05 | 848 | 52 | 10 | ratio_ECTO_vs_SC_2500_K3 |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.59e-05 | 266 | 52 | 6 | Arv_SC-hpx_blastocyst_1000_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell-hypoxiaGrown_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.68e-04 | 337 | 52 | 6 | Arv_SC-hpx_blastocyst_2500_K3 | |
| CoexpressionAtlas | AravindRamakr_StemCell-HD_top-relative-expression-ranked_500_k-means-cluster#2 | 2.57e-04 | 126 | 52 | 4 | Arv_SC-HD_500_K2 | |
| CoexpressionAtlas | AravindRamakr_StemCell_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500_k-means-cluster#3 | 3.73e-04 | 139 | 52 | 4 | Arv_SC_fibroblast_500_K3 | |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.85e-28 | 194 | 62 | 18 | 6ef4aeb8d8e35e4df58ff2a8256caa2113291de9 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 2.05e-26 | 195 | 62 | 17 | f3f7f1a77a1edd2b50a8211c76fe289738eb04cf |
| ToppCell | Biopsy_IPF-Immune-Plasma_cells|Biopsy_IPF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 PKHD1L1 | 2.25e-26 | 196 | 62 | 17 | a1b6a8000b86efcb07843998aa3a49bb1f54bcda |
| ToppCell | Control-Lymphoid_P|Control / Disease group, lineage and cell class | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 PKHD1L1 | 3.31e-23 | 176 | 62 | 15 | d895a6b295cd649273ff80ad7785a3e0ae4c728a |
| ToppCell | Control-Lymphoid_P-Plasmablast|Control / Disease group, lineage and cell class | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 PKHD1L1 | 3.31e-23 | 176 | 62 | 15 | 4b4416f342b732d2cc60133838728880326257d8 |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.37e-22 | 193 | 62 | 15 | 34f6c13884fdf7f8a87f942fcb36a58cfac3f65d |
| ToppCell | Parenchymal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.88e-22 | 197 | 62 | 15 | 9fe1b757f76c2d43d39aa9ac500eaba98723985c |
| ToppCell | COPD-Lymphoid-B_Plasma|World / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 2.64e-21 | 175 | 62 | 14 | d73ee324479172501481b54967a0f3bd870fcf3a |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 8.59e-21 | 190 | 62 | 14 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 8.59e-21 | 190 | 62 | 14 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.34e-20 | 196 | 62 | 14 | fec21383435779bf4c632decd3d29c6ca7baebfb |
| ToppCell | IPF-Lymphoid-B_Plasma|IPF / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 2.25e-19 | 176 | 62 | 13 | e4f33f6cd140dd4fa3002bcd65ac8005d27865d1 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 2.82e-19 | 179 | 62 | 13 | 494febe77c6d4e6a2c6f0928bbf4c84b0301f188 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.69e-19 | 186 | 62 | 13 | e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67 |
| ToppCell | Biopsy_Other_PF-Immune-Plasma_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 PKHD1L1 | 8.76e-19 | 195 | 62 | 13 | d0305c6a68c9e361507b04db94f86873085d49b3 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-27 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 9.37e-19 | 196 | 62 | 13 | c38e7f533c619afe008de0e99042f7180c2da918 |
| ToppCell | 368C-Lymphocytic-Plasma_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-13 IGKV1D-12 PKHD1L1 | 5.80e-18 | 162 | 62 | 12 | f945688815229c8386cbcbf46deee7df316fa8d3 |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-13 IGKV1D-12 PKHD1L1 | 5.80e-18 | 162 | 62 | 12 | c21a54310b239d999bbc9d8fb5e8fda16e0bc336 |
| ToppCell | metastatic_Brain-B_lymphocytes-MALT_B_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-39 IGKV1-27 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-13 IGKV1D-12 PKHD1L1 | 1.60e-17 | 176 | 62 | 12 | 50e207403d48ce1b55a78897adb5519a2430a626 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.97e-17 | 179 | 62 | 12 | 837ed81f18257f444eaeadc4fac89deedd4e3061 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.97e-17 | 179 | 62 | 12 | b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-17 IGKV1D-13 | 2.25e-17 | 181 | 62 | 12 | e47664a264a2c37390d1668ce04eef2e0172f4cb |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 PKHD1L1 | 2.57e-17 | 183 | 62 | 12 | cf5c98f451a568308c52da5c926543dd4836c6b2 |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | IGKV1-17 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-42 IGKV1D-39 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 3.57e-17 | 188 | 62 | 12 | bd53b0371154cff680226897b61c9809a239d1b6 |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | IGKV1-39 IGKV1-17 IGKV1-16 CLDN14 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-16 IGKV1D-13 PKHD1L1 | 3.81e-17 | 189 | 62 | 12 | 5a42be62552d912d0abf68f00d75ac80bbd69f2c |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 | 4.33e-17 | 191 | 62 | 12 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 4.92e-17 | 193 | 62 | 12 | 282b47dae6043eabb1e13d41d91c07b5ec21cd65 |
| ToppCell | Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-37 IGKV1D-16 IGKV1D-13 PKHD1L1 | 5.58e-17 | 195 | 62 | 12 | 13f4ee21568fd747608412d33559d10561dbb3c8 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 5.58e-17 | 195 | 62 | 12 | df009b18898c10686f75cf72b4ec0eff18f5bb50 |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-37 PKHD1L1 | 3.29e-16 | 159 | 62 | 11 | 204e5a675f4684c9570c24c8d34bbf632fd8164a |
| ToppCell | metastatic_Brain-B_lymphocytes-Plasma_cells|metastatic_Brain / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-17 PKHD1L1 | 6.95e-16 | 170 | 62 | 11 | 53634da9e9c72f6400639954c286c6e38ea5a188 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.09e-15 | 177 | 62 | 11 | 4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd |
| ToppCell | (2)_Plasma_cells|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | IGKV1-39 IGKV1-37 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-16 PKHD1L1 | 1.09e-15 | 177 | 62 | 11 | ed3c936bb69f9bc7291b4f6cde1d204078117c48 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.09e-15 | 177 | 62 | 11 | fc40918825b7e1eb6861df59dfca944778a64b98 |
| ToppCell | PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-37 IGKV1D-17 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 1.09e-15 | 177 | 62 | 11 | d746122bf8d208c3aa4d156e8c12d0a0e555c6e5 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells|Liver / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-13 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 IGKV1D-13 IGKV1D-12 PKHD1L1 | 1.68e-15 | 184 | 62 | 11 | 6f70d8f8ab8362d51f8a58735d42223e06566397 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-13 PKHD1L1 | 1.78e-15 | 185 | 62 | 11 | 0fff2608f507e019ebb69c27e58fd5be3b049bef |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-13 PKHD1L1 | 1.78e-15 | 185 | 62 | 11 | 79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9 |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-13 IGKV1D-12 | 3.58e-15 | 197 | 62 | 11 | 2662138671262b30508c5759038bcdcfe6551696 |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|normal_Lung / Location, Cell class and cell subclass | IGKV1-39 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-13 PKHD1L1 | 2.09e-14 | 159 | 62 | 10 | fbd0131b66f4267f7b0d6c3ad874ad097b859074 |
| ToppCell | 10x5'-GI_large-bowel|World / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-16 | 3.66e-14 | 168 | 62 | 10 | 1290c909655bc37f6b8bf216d18127a21b99e9c0 |
| ToppCell | Plasma_cells|World / lung cells shred on cell class, cell subclass, sample id | IGKV1-39 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 PKHD1L1 | 4.92e-14 | 173 | 62 | 10 | 52a387e2a4694af61a9223a4c2ecf4e6f762c064 |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-Plasmablast|Multiple_Sclerosis / Disease, Lineage and Cell Type | KIF20A PREB IGKV1-16 IGKV1-13 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-13 SEC61A1 PKHD1L1 | 5.21e-14 | 174 | 62 | 10 | e8d2aa9505817aac3fe068080774d19458f07b01 |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | IGKV1-39 IGKV1-16 CLDN14 IGKV1-13 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-13 IGKV1D-12 PKHD1L1 | 6.19e-14 | 177 | 62 | 10 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | IGKV1-39 IGKV1-16 CLDN14 IGKV1-13 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-13 IGKV1D-12 PKHD1L1 | 6.19e-14 | 177 | 62 | 10 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 PKHD1L1 | 9.66e-14 | 185 | 62 | 10 | 6ec009e48e50471c28e914c402f500e56a88f8f2 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 PKHD1L1 | 9.66e-14 | 185 | 62 | 10 | f49ad6401b2abd089e30eba245b11b5031ea2318 |
| ToppCell | IPF-Lymphoid-B_Plasma|Lymphoid / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-17 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-17 IGKV1D-12 | 1.02e-13 | 186 | 62 | 10 | f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-37 IGKV1-17 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 IGKV1D-17 IGKV1D-12 | 1.56e-13 | 194 | 62 | 10 | a4a70369541876e1192df8828b63e3d1746ae3d9 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-17 IGKV1-16 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-16 PKHD1L1 | 1.64e-13 | 195 | 62 | 10 | 2d18f08f33f3b261c77b8adf87d1a184cc6d7400 |
| ToppCell | COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast|COVID_vent / Disease condition, Lineage, Cell class and subclass | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 IGKV1D-17 SEC61A1 | 1.73e-13 | 196 | 62 | 10 | 026a06d8d2089806823e6f6453d3ede84ae93bc6 |
| ToppCell | COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-5 IGKV1-12 IGKV1-9 IGKV3D-15 IGKV1D-39 IGKV1D-13 SEC61A1 | 1.82e-13 | 197 | 62 | 10 | b754fad4f3caae6de95df901fd96ea8697fe41b1 |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-12 PKHD1L1 | 2.05e-12 | 169 | 62 | 9 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 |
| ToppCell | tumor_Lung-B_lymphocytes-Plasma_cells|tumor_Lung / Location, Cell class and cell subclass | IGKV1-27 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-39 PKHD1L1 | 2.05e-12 | 169 | 62 | 9 | b36b7632ce55fc7b6b8b66020563d360b3de6fd7 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-12 PKHD1L1 | 2.17e-12 | 170 | 62 | 9 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-12 PKHD1L1 | 2.17e-12 | 170 | 62 | 9 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 IGKV1D-12 PKHD1L1 | 2.17e-12 | 170 | 62 | 9 | 52787f6d529c285d9f0c04cc022710ead5b89b3f |
| ToppCell | Control-Lymphoid-B_Plasma|Control / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 | 2.41e-12 | 172 | 62 | 9 | 61e33836b8cb0f347f3e699eb587a37073b6fa4c |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-37 CLDN14 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 3.63e-12 | 180 | 62 | 9 | e3877f6ef5f54ff689058b4c996ab1851822f871 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasma_cells|lymph-node_spleen / Manually curated celltypes from each tissue | IGKV1-17 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 SEC61A1 | 4.21e-12 | 183 | 62 | 9 | a6866951866373a1029e04818f4a4a31278c409d |
| ToppCell | Mild-Lymphoid-B|Mild / Condition, Lineage, Cell class and cell subclass | IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 4.21e-12 | 183 | 62 | 9 | 9b64d2d143525e6f48a191facfd101462ff36324 |
| ToppCell | cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | IGKV1-39 CLDN14 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.21e-12 | 183 | 62 | 9 | 5ab4aa0304b832f98fff89b6c24ad5b7dd014c11 |
| ToppCell | 368C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 SEC61A1 | 4.21e-12 | 183 | 62 | 9 | d91441cbf94f5c3b7c36f2ca3a46895870bd730f |
| ToppCell | 368C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV3D-15 IGKV1D-39 SEC61A1 | 4.21e-12 | 183 | 62 | 9 | 7733cf919eda146efe41c93990658ce92db73aa8 |
| ToppCell | Mild-Lymphoid-B-|Mild / Condition, Lineage, Cell class and cell subclass | IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 4.21e-12 | 183 | 62 | 9 | b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.64e-12 | 185 | 62 | 9 | 08bc817908076734d66f2805cb954141f2cc5a18 |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-39 IGKV1-17 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-13 IGKV1D-12 | 4.64e-12 | 185 | 62 | 9 | 1704a12153a9b107bf03ecccd1a036cf61334d7a |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | PREB IGKV1-27 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-17 IGKV1D-16 IGKV1D-13 PKHD1L1 | 6.19e-12 | 191 | 62 | 9 | da4062a0f6d0af6d330acf11da216c64b0fa7c73 |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV3D-15 IGKV1D-17 IGKV1D-13 | 7.12e-12 | 194 | 62 | 9 | f083777353e76a2d9c39f8b6cb1a689b68b81c56 |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | IGKV1-39 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-16 IGKV1D-13 PKHD1L1 | 7.81e-12 | 196 | 62 | 9 | b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584 |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Plasma_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | IGKV1-37 IGKV1-27 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-37 | 2.36e-11 | 142 | 62 | 8 | 5ba3a33c2ee20be8baaed97536ca6e9d1de6752f |
| ToppCell | 10x5'-blood-Lymphocytic_B_plasma|blood / Manually curated celltypes from each tissue | PREB IGKV1-16 IGKV1-13 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-13 PKHD1L1 | 3.67e-11 | 150 | 62 | 8 | 6bab0a8bf78ed7de9e1b67ede7496488f80f4863 |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-27 CLDN14 IGKV1-12 IGKV1D-39 IGKV1D-16 PKHD1L1 | 5.29e-11 | 157 | 62 | 8 | 554ddbaf83f5d6eb4669c673efdbb28fd87e2ba8 |
| ToppCell | 343B-Lymphocytic-Plasma_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-27 CLDN14 IGKV1-12 IGKV1D-39 IGKV1D-16 PKHD1L1 | 5.29e-11 | 157 | 62 | 8 | 2cb3deb5313ce734710c601935ca318e4179077e |
| ToppCell | 343B-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-27 CLDN14 IGKV1-12 IGKV1D-39 IGKV1D-16 PKHD1L1 | 7.51e-11 | 164 | 62 | 8 | cf62d34ce9dd220fe61748466c84fd70d9ba697c |
| ToppCell | 343B-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 IGKV1-27 CLDN14 IGKV1-12 IGKV1D-39 IGKV1D-16 PKHD1L1 | 7.51e-11 | 164 | 62 | 8 | e00549bc8b3a5566f39031f39d7e698b0b107a7f |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|367C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 IGKV1D-12 | 8.68e-11 | 167 | 62 | 8 | f2185eb72f0137136f6d71af2a70168fded6c940 |
| ToppCell | 367C-Lymphocytic-Plasma_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 IGKV1-37 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 IGKV1D-12 | 8.68e-11 | 167 | 62 | 8 | 5e768cf24699893e05d1bcb1c92dba2336943a64 |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | IGKV1-39 RAG1 IGKV1-17 IGKV1-13 ARPP21 IGKV3D-15 IGKV1D-39 IGKV1D-13 | 1.10e-10 | 172 | 62 | 8 | d1ab8f493b70ec995281f9fb0991f1d3aa7b928f |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B_plasma-Plasma_cells|bone_marrow / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-27 IGKV1-13 IGKV1-5 IGKV1-6 IGKV3D-15 IGKV1D-39 IGKV1D-13 | 1.15e-10 | 173 | 62 | 8 | 300904fd35536a69be81d76fe33fe16544523ceb |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgG_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | IGKV1-39 IGKV1-5 IGKV1-12 IGKV3D-15 IGKV1D-39 IGKV1D-16 IGKV1D-12 PKHD1L1 | 1.26e-10 | 175 | 62 | 8 | c3d3f11602379aaba65842a98835299e54fccd84 |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.38e-10 | 177 | 62 | 8 | c2b0fb5921eea24d248d6e6ccb57c29b0832602c |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.38e-10 | 177 | 62 | 8 | 111fb0707ff37ca631d85bb5a09e067ffe568eb8 |
| ToppCell | COPD-Lymphoid-B_Plasma|COPD / Disease state, Lineage and Cell class | IGKV1-39 IGKV1-17 CLDN14 IGKV1-13 IGKV1-5 IGKV1-12 IGKV1D-39 IGKV1D-17 | 1.38e-10 | 177 | 62 | 8 | 1b872d3b1e0fca138362098590a634d748dfca60 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-17 | 1.58e-10 | 180 | 62 | 8 | cea079bc02e08c46600eed05ab9924ec90e1e3d3 |
| ToppCell | normal_Lymph_Node-B_lymphocytes-Plasma_cells|normal_Lymph_Node / Location, Cell class and cell subclass | IGKV1-27 IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 IGKV1D-12 | 1.65e-10 | 181 | 62 | 8 | 949ac3b60e7fb5968da4c4e872965fb4e10f4a35 |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.65e-10 | 181 | 62 | 8 | 700adfb41e4e377530f0dd31be89e12f109f3469 |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-37 CLDN14 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-13 PKHD1L1 | 1.72e-10 | 182 | 62 | 8 | 1bf2e4fd6222b41a7d08df6dcc500c9401db8c18 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.88e-10 | 184 | 62 | 8 | 3f8a359e40bebe58545f708682e5e5d1b70cf5cb |
| ToppCell | 367C-Lymphocytic-Plasma_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 SEC61A1 PKHD1L1 | 1.88e-10 | 184 | 62 | 8 | fc708a5c8a7b19fab973c72dc4383a7d30f8b59a |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.88e-10 | 184 | 62 | 8 | 64bede8db709fd32f40c03265b96f0b12155bb8a |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-16 | 1.88e-10 | 184 | 62 | 8 | 15f2c10101ccc8ed059520fc082ee42593dff269 |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-16 | 1.88e-10 | 184 | 62 | 8 | a90a58d9e319afa1cd572e4c2f516fadc42f56e5 |
| ToppCell | 367C-Lymphocytic-Plasma_cell-|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | IGKV1-39 CLDN14 IGKV1-5 IGKV1-12 IGKV1-6 IGKV1D-39 SEC61A1 PKHD1L1 | 1.88e-10 | 184 | 62 | 8 | 14a5288d861260f63fbe0cbea3569cf643e7597e |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-MALT_B_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | PREB IGKV1-17 CLDN14 IGKV1-5 IGKV1-12 IGKV1D-13 SEC61A1 PKHD1L1 | 1.96e-10 | 185 | 62 | 8 | bb87fa174f80706fe7be60d3b9fc3e2a6b373038 |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | IGKV1-39 IGKV1-16 IGKV1-5 IGKV1-12 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 1.96e-10 | 185 | 62 | 8 | 609080adb2cfb105bb7b8efb617553833299f371 |
| ToppCell | 10x5'-Liver-Lymphocytic_B_plasma|Liver / Manually curated celltypes from each tissue | IGKV1-39 IGKV1-17 IGKV1-13 IGKV1-9 IGKV3D-15 IGKV1D-39 IGKV1D-13 PKHD1L1 | 2.05e-10 | 186 | 62 | 8 | a2c7430781f432c9c90ac4d620f4518ff767a223 |
| ToppCell | Mild_COVID-19-B_cell-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1-6 IGKV1D-39 PKHD1L1 | 2.05e-10 | 186 | 62 | 8 | 855a5a00ba2aa1b5c63b8db56d026ddecc546050 |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-MALT_B_cells|normal_Pleural_Fluid / Location, Cell class and cell subclass | PREB CLDN14 IGKV1-12 IGKV1-9 IGKV1D-39 IGKV1D-13 SEC61A1 PKHD1L1 | 2.33e-10 | 189 | 62 | 8 | 05e8fb483ebb9010cc54b39d78cca960c58c0f01 |
| ToppCell | COVID-19-Lymphoid-Plasma,_B_cells|COVID-19 / Condition, Lineage and Cell class | IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1-9 IGKV1D-39 IGKV1D-17 PKHD1L1 | 2.75e-10 | 193 | 62 | 8 | bffd97a73365e1dd23ff3b0320b4860f04ec091a |
| Disease | COMM domain-containing protein 1 measurement | 2.81e-06 | 2 | 50 | 2 | EFO_0802424 | |
| Disease | level of nuclear factor NF-kappa-B p105 subunit in blood serum | 2.81e-06 | 2 | 50 | 2 | OBA_2040323 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.30e-04 | 152 | 50 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | receptive language perception, parental genotype effect measurement | 2.53e-04 | 14 | 50 | 2 | EFO_0005686, EFO_0005939 | |
| Disease | biological sex | 6.25e-04 | 230 | 50 | 4 | PATO_0000047 | |
| Disease | Vertigo | 1.71e-03 | 139 | 50 | 3 | HP_0002321 | |
| Disease | Parkinson disease, disease progression measurement | 2.00e-03 | 39 | 50 | 2 | EFO_0008336, MONDO_0005180 | |
| Disease | epilepsy (implicated_via_orthology) | 2.68e-03 | 163 | 50 | 3 | DOID:1826 (implicated_via_orthology) | |
| Disease | aspartate aminotransferase measurement | 4.10e-03 | 904 | 50 | 6 | EFO_0004736 | |
| Disease | response to antipsychotic drug | 4.68e-03 | 60 | 50 | 2 | GO_0097332 | |
| Disease | psoriasis vulgaris | 4.83e-03 | 61 | 50 | 2 | EFO_1001494 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLSATLGGEESLTIF | 136 | Q76B58 | |
| SGDELTELLAGITGT | 221 | P30281 | |
| GGSGLSRLDTSVIFE | 96 | Q9UKU7 | |
| EGSTLSGVDFELVGT | 776 | Q0JRZ9 | |
| DLFDLTSGVGTLSGS | 701 | Q10567 | |
| TASFGGITVLTRGDS | 381 | Q9UBL0 | |
| SSTDVGIIDGLSGLS | 531 | P15918 | |
| SLFEELSSAGSGLIG | 381 | O60271 | |
| GSGSGTDFTLTISSL | 86 | P04432 | |
| GTLDLGGASTQITFL | 196 | O75356 | |
| GSGSGTDFTLTISSL | 86 | P01611 | |
| IFGSGSDETTTLIGL | 511 | Q9NS40 | |
| GSGSGTDFTLTISSL | 86 | P0DSN7 | |
| GSGSGTDFTLTISSL | 86 | A0A0B4J2D9 | |
| SATELGTTVSFTGGL | 2176 | Q7Z5P9 | |
| GLSAGVTETIGLSAE | 4016 | Q7Z5P9 | |
| GTTGLSAEATEITGL | 5721 | Q7Z5P9 | |
| GIVTGSGEVTFSLES | 56 | O60245 | |
| GSGSGTEFTLTISSL | 86 | A0A075B6S4 | |
| GSGTEFTLTISILQS | 86 | A0A087WSY6 | |
| LERSSGLGVSGSTLT | 2141 | P16112 | |
| GISSSTTLGFRIEGI | 321 | P23677 | |
| ESSEGISFVLLGLTT | 6 | Q8NGR3 | |
| GDLGVTLSFSGLQTL | 776 | Q13349 | |
| DTTISTGLVGGSYDV | 1996 | Q8NFC6 | |
| TTGDGALDTFTGSVI | 111 | O95677 | |
| LGFISSSLSLIGGTL | 166 | O95500 | |
| DTLGAGFLGTTTEVF | 36 | A6NK06 | |
| GSGSGTEFTLTISSL | 86 | P01602 | |
| GSGSGTDFTLTISSL | 86 | A0A0C4DH72 | |
| GSGSGTEFTLTISSL | 86 | A0A0C4DH69 | |
| GSGSGTDFTLTISSL | 86 | A0A0C4DH73 | |
| GSGSGTDFTLTISSL | 86 | P0DP09 | |
| GSGSGTDFTLTISSL | 86 | P04430 | |
| GSGSGTEFTLTISSL | 86 | P01599 | |
| GSGSGTDFTLTISSL | 86 | A0A075B6S5 | |
| GSGSGTDFTLTISSL | 86 | A0A075B6S9 | |
| GSGSGTDFTLTISSL | 86 | P01597 | |
| DILGATGSDSLTLVF | 431 | O15523 | |
| GGLTTITGTSTNLIF | 251 | Q9BZW2 | |
| DGLLLSTELSEGSGT | 401 | Q8WYK1 | |
| STELSEGSGTLLLSL | 406 | Q8WYK1 | |
| LGFSITSRDVTIGGS | 471 | Q8TEW0 | |
| GTFLLRFSESSEGGI | 596 | P52630 | |
| LSVLADFLGAIGSGT | 431 | Q9H9S3 | |
| GDGTTSVTLLAAEFL | 91 | Q99832 | |
| FLLSATLGGEESLTI | 146 | Q9C0B6 | |
| LLSIISEEAGGGSTF | 71 | Q9UKZ1 | |
| LDVSESGTFLGLGTV | 306 | Q9HCU5 | |
| SSGDGFEEGLTVATV | 416 | Q9H4B4 | |
| LTFGSAISESLIGTE | 351 | O14709 | |
| LSVLADFLGAIGSGT | 431 | P61619 | |
| FSVTGTSLLSGGRES | 256 | Q8IWA0 | |
| IGTSTSFDSGIAGLS | 251 | O95235 | |
| TGILTSEGLASDTSL | 121 | Q5T4T6 | |
| ISSSLAGLIDGSFEI | 61 | Q9NPD5 | |
| LETALGQFTSEGGIT | 106 | P48066 | |
| AISGLLDISGSTFVG | 3601 | Q86WI1 | |
| DTGDTLGSVLRGFFT | 1006 | Q7Z3V4 | |
| SSGEDGIVVFSLGSL | 296 | Q6UWM9 | |
| GLVTLLSTGTLAFED | 941 | Q01118 | |
| LDLGTESVSGTLSSL | 361 | Q6ZVM7 | |
| SDSLTLAVGTGRFSG | 11 | Q8N6I4 | |
| TSVGTGTRSLLGLDS | 1071 | P49815 | |
| GSGSGTDFTLTISSL | 86 | P01601 | |
| GRGSGTDFTLTIISL | 86 | A0A075B6H8 |